Notable Analyst Rating Changes 02/17: (BMR) (ANF) (ESV) (HPY) (EP) Upgraded; (OWW) (HBAN) (CTRN) (SNV) Downgraded
Tweet Send to a Friend
UPGRADES
FBR Capital upgraded BioMed Realty (NYSE: BMR) from Market Perform to Outperform, with a price target of $19 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
FBR Capital upgraded BioMed Realty (NYSE: BMR) from Market Perform to Outperform, with a price target of $19 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
